ftInvstr

AGARWALEYE · Healthcare ₹537.0 +4.35% Mkt Cap ₹17036 Cr overvalued

AGARWALEYE

Healthcare Medical Instruments & Supplies

★ Watchlist ⧉ Add to bucket

₹537.0

+4.35% today · 30d +12.82%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for AGARWALEYE. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-09-30

REVENUE

₹655 Cr

+31.44% YoY

NET PROFIT

₹57 Cr

+55.8% YoY

OPM

27.89%

-0.54pp YoY

EPS

₹1.65

PE 100.94

Intrinsic value · DCF ₹76.63 · Margin of safety -85.7% (overvalued) · FCF yield 0.42%

◇ Sector Position

PEERPEROCE %

AGARWALEYE100.9410.0

LENSKART156.0516.25

POLYMED52.5719.47

TARSONS151.3314.03

+ 1 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance POSITIVE 55

Valuation STRETCHED 5

Growth STRONG 82

Profitability HIGH 75

Technicals NEUTRAL 58

Risk LOW 90

Key Stats

TTM PE

100.94

P/B

8.22

52W HIGH

₹567.75

OFF HIGH

-5.42%

DIV YIELD

0.0%

MKT CAP

₹17036 Cr

◉ Active Signals

MACDBullish5.7457

RSI(14)Bullish68.54

Street Consensus

6 analysts

₹606.17

mean target

Low ₹555.0Now ₹537.0High ₹652.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AGARWALEYE and at what entry.